Zusammenfassung
Prolaktin unterliegt, ebenso wie andere neuroendokrine Systeme, der Beeinflussung durch externe und interne Variablen (siehe Abb. 10). Von den Neurotransmittern spielen, wie in Abb. 11 dargestellt, Dopamin und Serotonin die wichtigste Rolle. Während Dopamin die Ausschüttung hemmt, bewirkt Serotonin eine Aktivierung der Prolaktinsekretion. Eine Hemmung der dopaminergen tuberoinfundibulären Bahnen, die z.B. durch typische Neuroleptika initiiert wird, resultiert in einem Prolaktinanstieg.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Brown WA, Laughren T. LOW serum prolactin and early relapse following neuroleptic withdrawal. AM J Psychiatry 1981; 138: 237–239.
Cauter E Van, Linkowski P, Kerkhofs M, Hubain P, L’hermite- Baleriaux M, Leclercq R, Brasseur M, Copinschi G, Mendlewicz J. Circadian and sleep-related endocrine rhythms in schizophrenia. Arch Gen Psychiatry 1991; 48: 348–356.
Davis BM, Davis KL, Mohs RD, Mathe AA, Rothpearl AB, Johns CA, Levy MI, Horvath TB. Evaluating prolactin response to dopamine agonists in schizophrenia. Arch Gen Psychiatry 1985; 42: 259–264.
Hays SE, Poland RE, Rubin RT. Prolactin releasing potencies of antipsychotic and related nonantipsychotic compounds in female rats: relation to clinical potencies. J Pharmacol Exp Ther 1980; 214: 362–367.
Kasper S, Sack DA, Wehr TA, Kick H, Voll G, Vieira A. Nocturnal TSH and prolactin secretion during sleep deprivation and prediction of antidepressant response in patients with major depression. Biol Psychiatry 1988; 24: 631–631.
Kemali D, Maj M, Ariano MG, Arena F, Lovero N. 24-hour plasma levels of prolactin, Cortisol, growth hormone and catecholamines in schizophrenic patients. Neuropsychobiology 1985; 14: 109–114.
Linkowski P, Hubain P, Von Frenckell R, Mendlewicz J. Haloperidol plasma levels and clinical response in paranoid schizophrenics. Eur Arch Psychiatry Clin Neurosci 1984; 234: 231–236.
Linkowski P, Van Cauter E, L’hermite-Baleriaux M, Kerkhofs M, Hubain P, L’hermite M, Mendlewicz J. The 24-hour profile of plasma prolactin in men with major endogenous de¬pressive illness. Arch Gen Psychiatry 1989; 46: 813–819.
Meltzer HY, Busch D, Fang VS. In: Brown GM, Reichlin S, Koslow S (eds.). Neuroendocrinology and Psychiatric Disorders. Raven Press: New York 1984, S. 1–28.
Meltzer HY, Fang V. The effect of neuroleptics on serum prolactin in schizophrenic patients. Arch Gen Psychiatry 1976; 33: 279–286.
Möller HJ, Kissling W, Maurach R, Schmid W, Doerr P, Pirke K, Von Zerssen D. Beziehungen zwischen Haloperidol-Serumspiegel, Prolactin-Serumspiegel, antipsychotischem Effekt und extrapyramidalen Begleitwirkungen. Pharmacopsychiatry 1981; 14: 27–34.
Naber D, Fischer H, Ackenheil M. Effect of longterm neuroleptic treatment on dopamine tuberoinfundibular system: development of tolerance? Commun Psychopharmacol 1979; 3: 59–65.
Rotrosen J, Angrist B, Gershon S, Paquin J, BrOleshanskyanchey L, Oleshansky M, Halpern F, Sachar EJ. Neuroendocrine effects on apomorphine: Characterisation of response patterns and application to schizophrenia research. Br J Psychiatry 1979; 135: 444–456.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 DUV/GWV Fachverlage GmbH, Wiesbaden
About this chapter
Cite this chapter
Kasper, S. (2004). Prolaktin. In: Volz, HP., Kasper, S., Möller, HJ. (eds) Kasuistische Beiträge zur modernen Pharmakotherapie mit Quetiapin. Deutscher Universitätsverlag. https://doi.org/10.1007/978-3-322-83447-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-322-83447-8_4
Publisher Name: Deutscher Universitätsverlag
Print ISBN: 978-3-8244-2174-9
Online ISBN: 978-3-322-83447-8
eBook Packages: Springer Book Archive